Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell

Cardiovascular Research

Volumn 28, Issue 1, 1994, Pages 1-15

  Piper, Hans Michael ^a   Noll, Thomas ^a   Siegmund, Berthold ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

CALCIUM CELL LEVEL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

CALCIUM; ENERGY METABOLISM; HUMAN; MITOCHONDRIA, HEART; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN; SUPPORT, NON-U.S. GOV'T;

EID: 85047676154     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/28.1.1     Document Type: Article

References (168)

1. Mertens S, Noll T, Spahr R, Krützfeldt A, Piper HM. Energetic response of coronary endothelial cells to hypoxia. Am J Physiol 1990;258:H689–94.
2. Paul RJ. Smooth muscle energetics. Annu Rev Physiol 1989;51:331–49.
3. Schömig A, Fischer S, Kurz Th, Richardt G, Schömig E. Nonexcytotic release of endogenous noradrenaline in the ischemic and anoxic heart: mechanism and metabolic requirements. Circ Res 1987;60:194–205.
4. Vanderkooi JM, Erecinska M, Silver IA. Oxygen in mammalian tissue: methods of measurement and affinities of various reactions Am J Physiol 1990;260:C1131–50.
5. 2 uptake in biological systems Biochem J 1986;236:765–9.
6. Noll T, Koop A, Piper HM. Mitochondrial ATP-synthase activity in cardiomyocytes after aerobic-anaerobic metabolic transition Am J Physiol 1992;262:C1297–303.
7. Wittenberg BA, Wittenberg JB. Oxygen pressure gradients in isolated cardiac myocytes. J Biol Chem 1985;260:6548–54.
8. Rumsey WL, Schlosser C, Matti Nuutinen E, Robiolio M. Wilson DF. Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. J BioI Chem 1990;265:15392–9.
9. Chance B. Reaction of oxygen with the respiratory chain in cells and tissue. J Gen Physiol 1965;49:163–88.
10. de Groot H, Noll T, Sies H. Oxygen dependence and subcellular partitioning of hepatic menadione-mediated oxygen uptake. Arch Biochem Biophys 1987;243:556–62.
11. Wittenberg BA, Wittenberg JB. Myoglobin-mediated oxygen delivery to mitochondria of isolated cardiac myocytes. Proc Natl Acad Sci USA 1987;84:7503–7.
12. Ito K, Nioka S, Chance B. Oxygen dependence of energy state and cardiac work in the perfused rat heart. Adv Exp Med Biol 1990;277:449–57.
13. Kübler W. Tierexperimentelle Untersuchungen zum Myokardstoffwechsel im Angina-pectori s-Anfall und beim Herzinfarkt. Basel: Karger, 1969.
14. Kübler W, Spieckermann PG. Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol 1970;1:351–77.
15. Bretschneider HJ, Gebhard MM, Preusse CJ. Cardioplegia. Principles and problems. In: Sperelakis N, ed. Physiology and pathophysiology of the heart. The Hague: Martinus Nijhoff: 1986:605–16.
16. Piper HM, Schwartz P, Hütter JF, Spieckermann PG. Energy metabolism and enzyme release of cultured adult rat heart muscle cells during anoxia. J Mol Cell Cardiol 1984;16:995–1007.
17. Kammermeier H, Roeb E, Jüngling E, Meyer B. Regulation of systolic force and control of free energy of ATP-hydrolysis in hypoxic hearts. J Mol Cell Cardiol 1990;22:707–13.
18. Fedela FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonges reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988;78:729–35.
19. Pantley GA, Malone SA, Rhen WS. et al Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res 1990;67:1481–93.
20. Ross J. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation 1991;83:1076–83.
21. Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 1992;70:1282–95.
22. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211–21.
23. Scott ID, Nicholls DG. Energy transduction in intact synaptosomes. Biochem J 1980;186:21–33.
24. Nicholls DG. Bioenergetics: An introduction to the chemiosmotic theory. London: Academic Press, 1980.
25. Harold FM. Membranes and energy transduction in bacteria. Curr Topics Bioenerg 1977;6:83–149.
26. Andersson BS, Aw TY, Jones DP. Mitochondrial transmembrane potential and pH gradient during anoxia. Am J Physiol 1987;252:C349–55.
27. LaNoue KF, Jeffries FMH, Radda GK. Kinetic control of mitochondrial ATP synthesis. Biochemistry 1986;25:7667–75.
28. 2+ in the function and dysfunction of heart mitochondria. In: Langer GA, ed. Calcium and the Heart. New York: Raven Press, 1990:167–98.
29. Lardy HA. Antibiotic inhibitors of mitochondrial energy transfer. In: Erecinska M, Wilson DF, eds. Inhibitors of mitochondrial function. Oxford: Pergamon Press, 1981;187–98.
30. Rouslin W. Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine 5’-triphosphatase in ischemic and autolyzing cardiac muscle. J Biol Chem 1983;258:9657–61.
31. Rouslin W, Erickson JL, Solaro RJ. Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am J Physiol 1986;250:H503–8.
32. Pullman ME, Monroy GC. A naturally occuring inhibitor of mitochondrial adenosine triphosphatase. J Biol Chem 1963;238:3862–9.
33. Schwerzmann K, Pedersen P. Regulation of the mitochondrial ATP synthase/ATPase complex. Arch Biochem Biophys 1986;250:1–18.
34. Rouslin W. Regulation of the mitochondrial ATPase in situ in cardiac muscle: role of the inhibitor unit. J Bioenerg Biomembr 1991;23:873–88.
35. Mittnacht S, Sherman SC, Farber JL. Reversal of ischemic mitochondrial dysfunction. J Biol Chem 1979;254:9871–78.
36. Aw TY, Andersson BS, Jones DP. Suppression of mitochondrial respiratory function after short-term anoxia. Am J Physiol 1987;252:C362–8.
37. Das AM, Harris DA. Control of mitochondrial ATP synthase in heart cells: inactive to active transitions caused by beating or positive inotropic agents. Cardiovasc Res 1990;24:411–7.
38. Rouslin W. The mitochondrial adenosine 5’-triphosphatase in slow and fast heart rate hearts. Am J Physiol 1987;252:H622–7.
39. Harris DA, Das AM. Control of mitochondrial ATP synthesis in the heart. Biochem J 1991;280:561–73.
40. Rouslin W, Broge CW, Grupp IL. ATP depletion and functional loss during ischemia in slow and fast-rate hearts. Am J Physiol 1990;259:H1759–66.
41. Piper HM. Sezer O, Schleyer M, Schwartz P, Hütter JF, Spieckermann PG. Development of ischemia-induced damage in defined mitochondrial subpopulations. J Mol Cell Cardiol 1985;17:186–98.
42. Piper HM, Das A. Detrimental actions of endogenous fatty acids and their derivatives. A study of ischaemic mitochondrial injury. Basic Res Cardiol 1987;82(suppl 1):187–96.
43. Lochner A, van Niederkerk I, Whitesell LF. Mitochondrial acyl-CoA, adenine nucleotide translocase activity and oxidative phosphorylation in myocardial ischemia. J Mol Cell Cardiol 1981;13:991–7.
44. Kotaka K. Miyazaki Y, Ogawa K, Satake T, Sugiyama S, Ozawa T. Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion. J Mol Cell Cardiol 1982;14:223–31.
45. Rouslin W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am J Physiol 1983;244:H743–8.
46. Hardy L, Clark JB, Darley-Usmar VM, Stone D. Reoxygenation-dependent decrease in mitochondrial NADH:CoQ reductase (Complex I) activity in the hypoxic/reoxygenated rat heart. Biochem J 1991;274:133–7.
47. Asimakis GK, Conti VR. Myocardial ischemia: correlation of mitochondrial adenine nucleotide and respiratory function. J MoI Cell Cardiol 1984;16:439–48.
48. Asimakis GK, Zwischenberger JB, Inners-McBride K, Sordahl LA, Conti VR. Postischemic recovery of mitochondrial adenine nucleotides in the heart. Circulation 1992;85:2212–20.
49. Klingenberg M. The ADP-ATP translocation in mitochondria: a membrane potential controlled transport. J Membr Biol 1980;56:97–105.
50. Klingenberg M. Molecular aspects of the adenine nucleotide carrier from mitochondria. Arch Biochem Biophys 1989;270:1–14.
51. Asimakis GK, Conti VR. Phosphate-induced efflux of adenine nucleotides from heart mitochondria. Am J Physiol 1985;249:H1009–16.
52. Shug AL, Shrago E, Bittar N, Folts JD, Roke JR. Acyl CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol 1975;228:689–92.
53. Regitz V, Paulson DJ, Hodach RJ, Little SE, Schaper W, Shug AL. Mitochondrial damage during myocardial ischemia. Basic Res Cardiol 1984;79:207–17.
54. Duan J, Karmazyn M. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion. Can J Physiol Pharmacol 1989;67:704–9.
55. Pande SV, Blanchaer MC. Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters. J Biol Chem 1971;246:402–11.
56. Shug AL, Lerner C, Elson O, Shrago E. The inhibition of adenine nucleotide translocase by oleoyl CoA and its reversal in rat liver mitochondria. Biochem Biophys Res Commun 1971;43:557–63.
57. Idell-Wenger JA, Grotyohann LW, Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 1978;253:4310–8.
58. Woldegiorgis G, Shrago E. The recognition of two specific binding sites of the adenine nucleotide translocase by palmityl CoA in bovine heart mitochondria and submitochondrial particles. Biochem Biophys Res Commun 1979;89:837–44.
59. Liedtke AJ, Shrago E. Detrimental effects of fatty acids and their derivatives in ischemic and reperfused myocardium. In: Piper HM, ed. Pathophysiology of severe ischemic myocardial injury. Dordrecht: Kluwer, 1990:149–66.
60. Van der Vusse GJ, van Bilsen M, Sonderkamp T, Reneman RS. Hydrolysis of phospholipids and cellular integrity. In: Piper HM. ed. Pathophysiology of severe ischemic myocardial injury. Dordrecht: Kluwer, 1990:167–94.
61. 2+activated hydrophilic channel of the mitochondrial inner membrane by nucleotides. J Membr Biol 1980;54:231–6.
62. Gunter TE, Pfeiffer DR. Mechanisms by which mitochondria transport calcium. Am J Physiol 1990;258:C755–86.
63. Harris EJ. Modulation of Ca efflux from heart mitochondria. Biochem J 1979;178:673–80.
64. Harris EJ, Cooper MB. Calcium and magnesium losses in response to stimulants of efflux applied to heart, liver and kidney mitochondria. Biochem Biophys Res Commun 1981;103:788–96.”
65. Sordahl LA, Stewart ML. Mechanism(s) of altered mitochondrial calcium transport in acutely ischemic canine hearts. Circ Res 1980;47:814–20.
66. Le Quoc K, Le Quoc D. Involvement of the ATP/ADP carrier in calcium-induced perturbations of the mitochondrial inner membrane permeability: importance of the orientation of the nucleotide binding site. Arch Biochem Biophys 1988;265:249–57.
67. Carbonera D, Azzone GF. Permeability of inner mitochondrial membrane and oxidative stress. Biochim Biophys Acta 1988;943:245–55.
68. 2+ release from heart mitochondria. J Biol Chem 1981;256:6742–50.
69. 2+ fluxes: role of free fatty acids, acyl CoA and acylcarnitine. Biochim Biophys Acta 1986;876:309–17.
70. 2+ release induced by t-butyl hydroperoxide or oxalacetate. J Biol Chem 1982;257:7161–71.
71. 2+, inorganic phosphate and oxidative stress. Eur J Biochem 1988;178:489–501.
72. + release from mitochondria induced bv prooxidants. Free Rad Biol Med 1988;4:365–75.
73. 2+ release from mitochondria by the oxidation-reduction state of pyridine nucleotides. Proc Natl Acad Sci USA 1978;75:1690–4.
74. Szabo I, Zoratti M. The mitochondrial megachannel is the permeability pore. J Bioenerg Biomembr 1992;24:111–7.
75. 2+ indicator arsenazo III in the matrix space of rat liver mitochondria by permeabilisation and resealing. Biochem J 1986;239:31–40.
76. 2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J 1988;255:357–60.
77. Nazareth W, Yafei N, Crompton M. Inhibition of anoxia-induced injury in heart myocytes by cyclosporin A. J Mol Cell Cardiol 1991;23:1351–4.
78. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in reglation of mammalian intramitochondrial metabolism. Physiol Rev 1990;70:391–425.
79. 2+ J. Biol Chem 1993;268:1011–6.
80. McGuiness O, Crompton M. Cyclosporin A and mitochondrial dysfunction. Biochem Soc Trans 1990;18:883–4.
81. Halestrap AP. Calcium-dependent opening of a non-specific pore in the mitochondrial inner membrane is inhibited at pH values below 7. Implications for the protective effect of low pH against chemical and hypoxic cell damage. Biochem J 1991;278:715–9.
82. 2+-dependent pore of possible relevance to reperfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. Biochem J 1990;266:33–9.
83. Kurokawa T, Kobayashi H, Nonami T. et al. Beneficial effects of cyclosporine on postischemic liver injury in rats. Transplantation 1992;53:308–11.
84. Shiga Y, Onodera H, Matsuo Y, Kogure K. Cyclosporin A protects against ischemia-reperfusion injury in the brain. Brain Res 1992;595:145–52.
85. Hansford RG. Relation between mitochondrial calcium transport and control of energy metabolism. Rev Physiol Biochem Pharmacol 1985;102:1–72.
86. 2+ concentration in living single rat cardiac myocytes. Am J Physiol 1991;261:H1123–34.
87. Nicholls DG. The regulation of extramitochondrial free calcium ion concentration by rat liver mitochondria. Biochem J 1978;176:463–74.
88. Lehninger AL. Mitochondria and calcium transport. Biochem J 1970;119:129–38.
89. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem 1987;56:395–433.
90. 2+-chelating agents. J Mol Cell Cardiol 1977;9:897–908.
91. Ferrari R, Williams A, Di Lisa F. The role of mitochondrial function in the ischemic and reperfused myocardium. In: Calderera CM, Harris P, eds. Advances in studies on heart metabolism. Bologna: CLUEB, 1988;245–55.
92. 2 inhibitors on the permeability of the liver mitochondrial inner membrane. J Biol Chem 1986;26:14018–24.
93. Walsh LG, Tormey JMcD. Subcellular electrolyte shifts during in vitro myocardial ischemia and reperfusion. Am J Physiol 1988;255:H917–28.
94. Walsh LG, Tormey JMcD. Cellular compartmentation in ischemic myocardium: indirect analysis by electron probe. Am J Physiol 1988;255:H929–36.
95. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, eds. The heart and cardiovascular system. Scientific foundations, 2nd ed. New York: Raven Press, 1990;1875–974.
96. Slater TF. Free radical mechanisms in tissue injury. Biochem J 1984;222:1–15.
97. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs. Phil Trans R Soc Lond B 1985;311:617–31.
98. Ferrari R, Curello S, Cargnoni A, et al. Importance of free radicals generated by endothelial and myocardial cells in ischemic and reperfusion. In: Piper HM, ed. Pathophysiology of severe ischemic myocardial injury. Dordrecht: Kluwer, 1990;221–38.
99. Turrens JF, Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 1980;191:421–7.
100. Nohl H, Jordan W. The mitochondrial site of superoxide formation. Biochem Biophys Res Commun 1986;138:533–9.
101. Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radie Res Commun 1991;12–13:681–9.
102. Arroyo CM, Kramer JH, Leiboff RH, Mergner GW, Dickens BF, Weglicki WB. Spin trapping of oxygen and carbon-centered free radicals in ischemic canine myocardium. Free Radie Biol Med 1987;3:313–6.
103. Nohl H. A novel superoxide radical generator in heart mitochondria. FEBS Lett 1987;214:269–73.
104. Vandeplassche G, Hermans C, Thone F, Borgers M. Mitochondrial hydrogen peroxide generation by NADH-oxidase activity following regional myocardial ischemia in the dog. J Mol Cell Cardiol 1989;21:383–4.
105. McCord JM. Free radicals and myocardial ischemia: overview and outlook. Free Radie Biol Med 1988;4:9–14.
106. Das DK, George A, Liu XK, Rao PS. Detection of hydroxyl radical in the mitochondria of ischemic-reperfused myocardium by trapping with salicylate. Biochem Biophys Res Commun 1989;165:1004–9.
107. Shlafer M, Myers CL, Adkins S. Mitochondrial hydrogen peroxide generation and activities of glutathione peroxidase and superoxide dismutase following global ischemia. J Mol Cell Cardiol 1987;19:1195–206.
108. Otani H, Tanaka H, Inoue T, et al. In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury. Circ Res 1984;55:168–75.
109. Ceconi C, Curello S, Cargnoni A, Ferrari R, Albertini A, Visioli O. The role of gluthatione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. J Mol Cell Cardiol 1988;20:5–13.
110. Liedtke AJ, Demaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988;62:535–42.
111. Laster SB, Becker LC, Ambrosio G, Jacobus WE. Reduced aerobic metabolic efficiency in globally “stunned” myocardium. J Mol Cell Cardiol 1989;21:419–26.
112. Dean EN, Shlafer M, Nicklas JM. The oxygen consumption paradox of “stunned myocardium” in dogs. Basic Res Cardiol 1990;85:120–31.
113. Hütter JF, Piper HM, Spieckermann PG. Effect of fatty acid oxidation on efficiency of energy production in rat heart. Am J Physiol 1985;249:H723–H728.
114. Nuutinen EM. Subcellular origin of the surface fluorescence of reduced nicotinamide nucleotides in the isolated perfused rat heart. Basic Res Cardiol 1984;79:49–58.
115. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD. NADH measurements in adult rat cardiomyocytes during simulated ischemia. Am J Physiol 1991;260:H1743–H1752.
116. Chance B. Pyridine nucleotides as an indicator of the oxygen requirements for energy-linked functions of mitochondria. Circ Res 1976;38:131–8.
117. Rafael J. 2-(Dimethylaminostyryl)-l-methylpyridimum iodide: a fluorescent probe of energetic conditions in brown-adipose-tissue mitochondria. Hoppe Seylers Z Physio! Chem 1980;361:437–44.
118. Fuchs J, Zimmer G, Bereiter-Hahn J. A multiparameter analysis of the perfused rat heart: responses to ischemia, uncouplers and drugs. Cell Biochem Funct 1987;5:245–53.
119. Sako EY, Kingsley-Hickman PB, From AHL, Foker JE, Ugurbil K. ATP synthesis kinetics and mitochondrial function in the postischemic myocardium as studied by “P NMR. J Biol Chem 1988;263:10600–7.
120. Zimmer HG, Trendelenburg C, Kammermeier H, Gerlach E. De novo synthesis of myocardial adenine nucleotides in the rat. Circ Res 1973;32:635–42.
121. Siegmund B, Koop A, Klietz T, Schwartz P, Piper HM. Sarcolemmal integrity and metabolic competence of cardiomyocytes under anoxia-reoxygenation. Am J Physiol 1990;258:H285–91.
122. Kammermeier H. High energy phosphate of the myocardium: concentration versus free energy change. Basic Res Cardiol 1987;82(suppl 2):31–6.
123. Siegmund B, Koop A, Piper HM. The use of the creatine kinase reaction to determine free energy change of ATP hydrolysis in anoxic cardiomyocytes. Pflügers Arch 1989;413:435–7.
124. Braunwald E, Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 1982;66:1146–9.
125. Mercier JC, Lando U, Kanmatsuse K, et al. Divergent effects of inotropic stimulation on the ischemic and severely depressed reperfused myocardium. Circulation 1982;66:397–400.
126. Ellis SG, Wyne J, Braunwald E, Henschke CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart J 1984;107:13–19.
127. Becker LC, Levine JH, Dipaula AF, Guarneri T. Anversano T. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and postsystolic potentiation. J Am Coll Cardiol 1986;7:580–9.
128. Ambrosio G, Jacobus WE, Bergman CA, Weisman HF, Becker LC. Preserved high-energy phosphate metabolic reserve in globally “stunned” hearts despite reduction of basal ATP content and contractility. J Mol Cell Cardiol 1987;19:953–64.
129. Gorge G, Chatelain P, Schaper J, Lerch R. Effects of increasing degrees of ischemic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts. Circ Res 1991;68:1681–92.
130. Nellis SH, Liedtke AJ, Renstrom B. Distribution of carbon flux within fatty acid utilization during myocardial ischemia and reperfusion. Circ Res 1991;69:779–90.
131. Hearse DJ, Humphrey SM, Chain EB. Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol 1973:5:395–407.
132. Ganote CE. Contraction band necrosis and irreversible myocardial injury. J Mol Cell Cardiol 1983;15:67–73.
133. Vander Heide RS, Angelo JP, Altschuld RA, Ganote CE. Energy dependence of contraction band formation in perfused hearts and isolated adult cardiomyocytes. Am J Pathol 1986;125:55–68.
134. 2+-overload. Am J Physiol 1992;263:H1262–H1269.
135. Siegmund B, Klietz T, Schwartz P, Piper HM. Temporary contractile blockade prevents hypercontracture in anoxic-reoxygenated cardiomyocytes. Am J Physiol 1991;260:H426–35.
136. Siegmund B, Schlüter KD, Piper HM. Calcium and the oxygen paradox. Cardiovasc Res 1993;27:1778–83.
137. 2+ in single rat heart cells during anoxia and reoxygenation. Biochem J 1987;244:381–5.
138. Li Q, Altschuld RA, Stokes BT. Myocyte deenergization and intracellular free calcium dynamics. Am J Physiol 1988;255:C162–8.
139. Miyata H, Lakatta EG, Stern MD, Silverman HS. Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 1992;17:605–13.
140. Marban E, Kitakaze M, Kusuoka H, Porterfield JK, Yue DT, Chacko VP. Intracellular free calcium concentration measured with “F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA 1987;84:6005–9.
141. Lee HC, Mohabir R, Smith N, Franz MR, Clusin WT. Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo-1. Circulation 1988;78:1047–59.
142. Steenbergen C, Murphy E, Levy L, London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemic in perfused rat heart. Circ Res 1987;60:700–7.
143. Kihara Y, Grossmann W, Morgan JR Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia, and reperfusion of the intact mammalian heart. Circ Res 1989;65:1029–44.
144. Marban E. Pathogenetic role for calcium in stunning. Cardiovasc Drugs Ther 1991;5:891–4.
145. Steenbergen C, Murphy E, Watts JE, London RE. Correlation between cytosolic free calcium, contracture, ATP, and irreversible injury in perfused rat heart. Circ Res 1990;66:135–46.
146. Piper HM. Energy deficiency, calcium overload or oxidative stress: possible causes of irreversible ischemic myocardial injury. Klin Wochenschr 1989;67:465–76.
147. Elz J, Nayler WG. Contractile activity and reperfusion-induced calcium gain after ischemia in the isolated rat heart. Lab Invest 1988;58:653–9.
148. Schlüter KD, Schwartz P, Siegmund B, Piper HM. Prevention of the oxygen paradox in anoxic-reoxygenated hearts. Am J Physiol 1991;261:H416–H423.
149. Garcia-Dorado D, Theroux P, Duran JM. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992;85:1160–74.
150. Übing A, Schlack W, Schäfer M, Bier F, Piper HM, Thämer V. Regional contractile blockade at the onset of reperfusion induces infarct size in dogs. (Abstract) Pflügers Arch 1993;421(suppl 1):23.
151. Reed KC, Bygrave FL. The inhibition of mitochondrial calcium transport by lanthanides and ruthenium red. Biochem J 1974;140:143–55.
152. McCormack JG, England PJ. Ruthenium red inhibits the activation of pyruvate dehydrogenase caused by positive inotropic agents in the perfused rat heart. Biochem J 1983;214:581–5.
153. 2+ concentration and the control of pyruvate dehydrogenase in isolated cardiac myocytes. Biochem J 1987;241:145–51.
154. Gupta MP, Innes IR, Dhalla NS. Response of contractile function to ruthenium red in rat heart. Am J Physiol 1988;255:H1413–20.
155. Imai K, Wang T, Millard RW, et al. Ischaemia-induced changes in canine cardiac sarcoplasmic reticulum. Cardiovasc Res 1983;17:696–709.
156. Dhalla NS, Panagia V, Singal PK, Makino N, Dixon IM, Eyolfosn DA. Alteration in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988;20(suppl II):3–13.
157. Krause SM, Jacobus WE, Becker LC. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic “stunned” myocardium. Circ Res 1989;65:526–30.
158. Yoshida Y, Shiga T, Imai S. Degradation of sarcoplasmic reticulum calcium pumping ATPase in ischemic-reperfused myocardium: role of calcium-activated neutral protease. Basic Res Cardiol 1990;85:495–507.
159. Limbruno U, Zucchi R, Ronca-Testoni S, Galbani P. Ronca G. Mariani M. Sarcoplasmic reticulum function in the “stunned” myocardium. J Mol Cell Cardiol 1989;21:1063–72.
160. Davis MD, Lebolt WR, Feher JJ. Reversibility of the effects of normothermic global ischemia on the ryanodine-sensitive and ryanodine-insensitive calcium uptake of cardiac sarcoplasmic reticulum. Circ Res 1992;70:163–71.
161. Kaplan P, Hendrikx M, Maettheussen M, Mubagwa K, Flameng W. Effect of ischemia and reperfusion on sarcoplasmic reticulum calcium uptake. Circ Res 1992;71:1123–30.
162. Peng CF, Kane JJ, Straub KD, Murphy ML. Improvement of mitochondrial energy production in ischemic myocardium by in vivo infusion of ruthenium red. J Cardiovasc Pharmacol 1980;2:45–54.
163. Ferrari R, de Lisa F, Raddino R, Visioli O. The effects of ruthenium red on mitochondrial function during post-ischemic reperfusion. J Mol Cell Cardiol 1983;14:737–40.
164. Ferrari T, Ceconi C, Curello S, et al. Metabolic changes during post-ischaemic reperfusion. J Mol Cell Cardiol 1988:20(suppl 2):119–33.
165. Park Y, Bowles DK, Kehrer JP. Protection against hypoxic injury in isolated-perfused rat heart in ruthenium red. J Pharmacol Exp Ther 1990;253:628–35.
166. Grover GJ, Dzwonczyk S, Sleph PG. Ruthenium red improves postischemic contractile function in isolated rat hearts. J Cardiovasc Pharmacol 1990;16:783–9.
167. Figueredo VM, Dresdner KP, Wolney AC, Keller AM. Postischemic reperfusion injury in the isolated rat heart: effect of ruthenium red. Cardiovasc Res 1991;25:337–42.
168. Benzi RH, Lerch R. Dissociation between contractile function and oxidative metabolism in postischemic myocardium. Attenuation by ruthenium red administered during reperfusion. Circ Res 1992;71:567–76.